Arthur A. Kornbluth

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Kornbluth during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

• Abbott Laboratories

Scientific Advisory Board:

• Abbott Laboratories; Alaven Pharmaceutical LLC; Biogen Idec; Centocor Ortho Biotech Inc.; Millennium Pharmaceuticals, Inc. (Takeda Pharmaceutical Company Limited ); Prometheus Laboratories Inc.; UCB S.A.

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

• Abbott Laboratories; Centocor Ortho Biotech Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.